Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Mar 24, 2024; 15(3): 378-380
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.378
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.378
Approaches and challenges in cancer immunotherapy pathways
Maria Kapritsou, Pathological Sector, Hellenic Anticancer Institute, "Saint Savvas" Hospital, Athens 11522, Greece
Author contributions: Kapritsou M wrote the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Maria Kapritsou, MSc, MSHCM, PhD, RN, Chief Nurse, Pathological Sector, Hellenic Anticancer Institute, "Saint Savvas" Hospital, Av Alexandras 171, Athens 11522, Greece. mariakaprit@gmail.com
Received: December 16, 2023
Peer-review started: December 16, 2023
First decision: January 10, 2024
Revised: January 23, 2024
Accepted: February 23, 2024
Article in press: February 23, 2024
Published online: March 24, 2024
Processing time: 96 Days and 15 Hours
Peer-review started: December 16, 2023
First decision: January 10, 2024
Revised: January 23, 2024
Accepted: February 23, 2024
Article in press: February 23, 2024
Published online: March 24, 2024
Processing time: 96 Days and 15 Hours
Core Tip
Core Tip: Immunotherapy has emerged as a potent treatment for specific cancer types, which evokes enduring reactions and sometimes even induces remission. Nevertheless, the efficiency of this method relies both on the type of malignancy involved and individual patient traits. Additionally, it is administered in tandem with surgical interventions or chemotherapy/radiation regimens. It holds promise but could not act as a panacea; ongoing studies focus on enhancing its efficacy levels while comprehending underlying mechanisms more precisely.